NEW YORK, Jan 31 – Nanogen said Wednesday its fourth quarter revenues rose to $3.0, compared with $2.0 million in the year ago quarter as revenues from sponsored research programs and corporate alliances increased and the company recognized revenue from the sale of its flagship product, the NanoChip Molecular Biology Workstation.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Robert Redfield is floated as the next director of the US Centers for Disease Control and Prevention, the Washington Post reports.

The New York Times writes that the National Institutes of Health's All of Us Research Program is "ambitious" and that some are concerned it might be overly so.

Representative Lamar Smith's criticism of the National Science Foundation has "changed the nature of the conversation," according to ScienceInsider.

In PLOS this week: non-coding RNA function in yeast, transcriptomic profiles of malaria parasites, and more.